Member Info for oogleflugal

Eck often seems to be the subject of mysterious big late reported trades ending the day with various different closing prices. The consensus seems to be 41.80p price will out in the end!

Highly recommend looking at the EpiVax website. Whether this is report is a commission or endorsement it is the best piece of news I have read about N4p. It almost worries me that there has been so little reaction to it. Why anyone would sell now is also quite weird. Any way new hope for holders and cancer sufferers. They must succeed.

At last some meaningful news. An email of a report that concludes that Nuvec could help the treatment of ‘refactory cancer’, a cancer that is resistant to either the beginning of conventional treatment or becomes resistant to repeated conventional treatments. The report should help progress towards clinical trials

As happens with many companies listed on AIM, they lose 90 percent or more of their value from listing , especially when they have no revenue and continually rely on placings to stay afloat. The advantage of being listed was shown when N4p was able to raise funds to buy Nanogenics recently, who not being listed could not raise the money they needed to stay afloat. This provides opportunities for listed companies to add T bargain prices. Don’t k ow why Nigel feels the need to RNS every single patent news. It’s hardly price sensitive news and they have a website and now an investor hub. Price sensitive news is when they start making money or get a partner.

And now tipped by Gervais at Premier Miton, long term holders, if somewhat reduced. Perhaps they will load up again!

Seems to have caught Paul Scott’s attention on Stockopedia at long last. Having appeared to be rather disinterested in recent years and the data they have is well of date, the positive update caught his eye fleetingly. What ever you think of his views there can be no doubt they carry some influence on the private investor and of course he is a very competent numbers man

Disappointing reaction.more or less expected in this climate . Good results -10 percent , mediocre results -25 percent, bad results -50 percent or ground zero. Paul Hill thinks fair value £9 with the success of Magnetica and Adaptix, which is looking more probable than not . Potential sale to fund investment ? The market is such a dick at the moment. Opportunity though

Going to need another placing for all the RNS releases!

Good for IG to hold as long as they did. Must be all of a week! Patent granted in India ‘shows the strength of their intellectual property.’ Look forward to the day we can say thank god they did that.

Monument the company that was spun out of Cog could be worth half their market cap. It’s quite ridiculous. They still have a 25 percent interest in that. Doesn’t mean it’s the bottom though. This is Aim , it’s mad!

Don’t know if people have seen the Eckoh Call Guard demo but highly recommend if invested. They claim to have more Fortune Five Hundred clients than their combined competitors. This is set to grow for very good reasons as explained in the Stella Asset Management interview with Paul Hill on Vox markets.

Typical reaction from a nervous market. There have been some similar reaction to strong results from other Aim companies this month. 18.8 revenue almost doubled to £36 million full year. Cash was up about £4 million after specially div of over £10 million. This was a strong in line performance. Should be more news about the permanent introduction of a dividend in March statement. Appointment of joint broker/financial advisor is interesting . Does that mean they don’t have much confidence in Singer? I’m sure there was mention of a partnership last year. Again will need to see March statement on that too. Griffith trimmed his holding from 29 percent to 23 percent, which is understandable. Stanley came aboard for 5 percent when the shares were high 60p’s. All looks pretty fine to me. Mills said if we get lucky should get bought out. I wondered if financial advisor has been installed for that eventuality. The world is not in a good place right now so the much talked about bull return looks to be on hold. Gl

Utterly pathetic response to great results. Well done Miles and team. Shows how screwed the market is right now. As usual the uk market is the most pathetic. Sadly I think we will eventually loose many of our best companies either to the USA where many operate a high percentage of their business or they just get bought out on the cheap by American investment companies

It maybe that the Syntec acquisition is finally paying its way. Brief mention in Stella Asset Management interview with Paul Hill on Vox Market last week. It could be that the Screwfix contract is an updated secure payment version, in which case it is a new contract theoretically. Not sure why it’s not worthy of an RNS. It seems the focus of the business is now firmly addressing the USA market which will be 90 percent of their business . Quite a seismic shift, and clearly a massive scale up. Stellar Asset say we should see a big step up from April. Look forward to it.

Feedback ‘how likely am I going to recommend N4p to another investor’ well Nigel once you realise the objective of a business is to make money and not just a 20 year loss making concept that keeps asking the market for more money, then I might just say this is more than just a very long trial going nowhere. Nowhereman please listen , seems obvious what your missing. All it is at the moment is university projects. One day Rodney……

Very exciting but no cigar

Trading statement any day now. Last year was Jan 17th. Extraordinary how quiet it has been. Should be dividend news and cash pile news! Gl

Whatever the absurdities of market movements I highly commend the Netflix program ‘you are what you eat’ to anyone who cares about food and where it comes from, building a very strong case for the need for all alternative food producers to be successful for the benefit for all and everyone.

Don’t know about the weekend but Paul Hill and Chris Harwood both have this at well over £5.00 fair value with nothing added for Adaptix or Magnetica. I guess that is typical of current markets. They did suggest some capital might be required to launch these two companies. The road show they did late last year seems to have been well received. No product likely to get sold till summer. Think that is holding us back at the moment. Just keep adding I think, but bear in mind possible small placing which they would easily get away at current SP and greatly oversubscribed no doubt . Expecting update next week on trading and no doubt Adaptix. Gl

That’s the Aim game. Tip off your mates. Then RNS and not forgetting the hub lastly